The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake

Nature Medicine

Volumn 6, Issue 7, 2000, Pages 802-807

  Tang Christensen, Mads ^a   Larsen, Philip Just ^a   Thulesen, Jesper ^a   Rømer, John ^b   Vrang, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PROTEIN 2; GLUCAGON RECEPTOR; NEUROPEPTIDE Y; PROGLUCAGON; PROTEIN C FOS; RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; FEEDING BEHAVIOR; FOOD INTAKE; HYPOTHALAMUS NUCLEUS; IMMUNOHISTOCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; TASTE AVERSION;

ANIMALS; CONDITIONING, OPERANT; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; DRINKING; EATING; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; HYPOTHALAMUS; MALE; NEUROPEPTIDE Y; NEUROTRANSMITTER AGENTS; PEPTIDE FRAGMENTS; PEPTIDES; PROGLUCAGON; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; TASTE;

ANIMALIA; RODENTIA;

EID: 0033914183     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/77535     Document Type: Article

References (40)

1. Holst, J.J. Enteroglucagon. Annu. Rev. Physiol. 59, 257-271 (1997).
2. Drucker, D.J. Glucagon-like peptides. Diabetes 47, 159-169 (1998).
3. Tang-Christensen, M. et al. Central administration of GLP-1(7-36)amide inhibits food and water intake in rats. Am. Jour. Phys. 271, 848-856 (1996).
4. Larsen, P.J., Tang-Christensen, M. & Jessop, D. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 138, 4445-4455 (1997).
5. Tang-Christensen, M., Vrang, N. & Larsen, P.J. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes 47, 530-537 (1998).
6. Gunn, I. et al. Central glucagon-like peptide-1 in the control of feeding. Biochem. Soc Trans. 24, 581-584 (1996).
7. McMahon, L.R. & Wellman, P.J. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am. J. Physiol. 274, R23-R29 (1998).
8. Turton, M.D. et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69-72 (1996).
9. Rinaman, L. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia. Am. J. Physiol. 277, R1537-R1540 (1999).
10. Seeley, R.J. et al. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride. J. Neurosci. 20, 1616-1621 (2000).
11. Munroe, D.G. et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc. Natl. Acad. Sci. USA 96, 1569-1573 (1999).
12. Larsen, P.J., Tang-Christensen, M., Holst, J.J. & Orskov, C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77, 257-270 (1997).
13. Merchenthaler, I., Lane, M. & Shughrue, P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J. Comp. Neurol. 403, 261-280 (1999).
14. Paxinos, G. & Watson, C. in The rat brain-in stereotxic coordinates 4th ed. 30-35 (Academic Press, San Diego, California, 1998).
15. Schwartz, M.W. et al. Insulin, neuropeptide Y, and food intake. Ann. N.Y. Acad. Sci. 692, 60-71 (1993).
16. Stanley, B.G. & Leibowitz, S.F. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc. Natl. Acad. Sci. USA 82, 3940-3943 (1985).
17. Valverde, I. et al. Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 132, 75-79 (1993).
18. Thorens, B. et al. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42, 1678-1682 (1993).
19. Brubaker, P.L. et al. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2. Endocrinology 138, 4837-4843 (1997).
20. Schepp, W. et al. Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2. Digestion 57, 398-405 (1996).
21. Van Dijk, G. et al. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. Am. J. Physiol. 271, R1096-R1100 (1996).
22. Thiele, T.E. et al. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am. J. Physiol. 272, R726-R730 (1997).
23. Yusta, B. et al. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor. J. Biol. Chem. 274, 30459-30467 (1999).
24. Schepp, W. et al. Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal celt receptor for glucagon-like peptide-1-(7-36)NH2. Eur. J. Pharmacol. 269, 183-191 (1994).
25. Serre, V. et al. Exendin (9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3′, 5′-monophosphate levels and beta-cell glucose competence. Endocrinology 139, 4448-4454 (1998).
26. Ørskov, C. et al. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J. Biol. Chem. 264, 1 2826-1 2829 (1989).
27. Bernardis, L.L. & Bellinger, L.L. The dorsomedial hypothalamic nucleus revisited: 1998 update. Proc. Soc. Exp. Biol. Med. 218, 284-306 (1998).
28. Ter Horst, G.J. & Luiten, P.G. Phaseolus vulgaris leuco-agglutinin tracing of intrahypothalamic connections of the lateral, ventromedial, dorsomedial and paraventricular hypothalamic nuclei in the rat. Brain Res. Bull. 18, 191-203 (1987).
29. Elmquist, J.K. et al. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 138, 839-842 (1997).
30. Pelletier, G. Ultrastructural localization of neuropeptide Y in the hypothalamus. Ann. N.Y. Acad. Sci. 611, 232-246 (1990).
31. Li, C., Chen, P. & Smith, M.S. The acute suckling stimulus induces expression of neuropeptide Y (NPY) in cells in the dorsomedial hypothalamus and increases NPY expression in the arcuate nucleus. Endocrinology 139, 1645-1652 (1998).
32. Li, C., Chen, P. & Smith, M.S. Neuropeptide Y (NPY) neurons in the arcuate nucleus (ARH) and dorsomedial nucleus (DMH), areas activated during lactation, project to the paraventricular nucleus of the hypothalamus (PVH). Regul. Pept. 75-76, 93-100 (1998).
33. Smith, M.S. Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat. Endocrinology 133, 1258-1265 (1993).
34. Wilding, J.P., Ajala, M.O., Lambert, P.D. & Bloom, S.R. Additive effects of lactation and food restriction to increase hypothalamic neuropeptide Y mRNA in rats. J. Endocrinol. 152, 365-369 (1997).
35. Kesterson, R.A. et al. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol. Endocrinol. 11, 630-637 (1997)
36. Thim, L. et al. Purification and characterisation of a new hypothalamic satiety peptide, cocaine and amphetamine regulated transcript (CART), produced in yeast. FEBS Lett. 428, 263-268 (1998).
37. Kristensen, P., Eriksen, J. & Dano, K. Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J. Histochem. Cytochem. 39, 341-349 (1991).
38. Jensen, J. et al. mRNA profiling of rat islet tumors reveals nkx 6.1 as a beta-cell-specific homeodomain transcription factor. J. Biol. Chem. 271, 18749-18758 (1996).
39. Woldbye, D.P. et al. Prolonged induction of c-fos in neuropeptide Y-and somatostatin-immunoreactive neurons of the rat dentate gyrus after electroconvulsive stimulation. Brain. Res. 720, 111-119 (1996).
40. Vrang, N., Larsen, P.J., Clausen, J.T. & Kristensen, P. Neurochemical characterization of hypothalamic cocaine-amphetamine-regulated transcript neurons J. Neurosci. 19, RC5 (1999).